Phase 2 (Data)
Amp Volatility Score
Catalyst Info & Data Links
TITLE: INO-5151 for Prostate Cancer - Phase 2 Data
ClinicalTrial.gov (NCT03835533): Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations (PORTER)
WHAT IS THE CATALYST EVENT?
Phase 2 Data
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
MECHANISM OF ACTION
INO-5151 is a combined formulation of INO-5150 (with SynCon® antigens encoding for PSA and PSMA) and INO-9012 (DNA vector expressing interleukin 12).
Updated by HC
INO, INO-5151, Prostate Cancer
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post